K. Lucas

发表

D. Krishnadas, F. Bai, K. Lucas, 2013, ImmunoTargets and therapy.

Interferon-gamma expressing EBV LMP2A-specific T cells for cellular immunotherapy.

K. Lucas, R. Burton, Lipai Chen, 2007, Cellular immunology.

Adoptive immunotherapy with allogeneic Epstein–Barr virus (EBV)‐specific cytotoxic T‐lymphocytes for recurrent, EBV‐positive Hodgkin disease

K. Lucas, Qi Sun, D. Salzman, 2004, Cancer.

Immunotherapy for Epstein – Barr Virus-Associated Tumors

K. Lucas, M. Comito, Qi Sun, 2004, Leukemia & lymphoma.

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

J. Kurtzberg, G. Broadwater, V. Prasad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dendritic cell vaccines: A review of recent developments and their potential pediatric application

D. Krishnadas, K. Lucas, Jennifer D. Elster, 2016, Human vaccines & immunotherapeutics.

A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

L. Diller, R. George, S. Shusterman, 2015, Cancer Immunology, Immunotherapy.

Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1

D. Krishnadas, F. Bai, K. Lucas, 2014, Tumor Biology.

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

K. Lucas, L. Bao, Kimberly Dunham, 2011, Cancer Immunology, Immunotherapy.

Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma

D. Krishnadas, K. Lucas, T. Shapiro, 2013, Pediatrics.

B Lymphoblastoid Cell Lines as Efficient APC to Elicit CD8+ T Cell Responses Against a Cytomegalovirus Antigen1

W. Britt, Q. Sun, K. Lucas, 2000, The Journal of Immunology.

Current Therapeutic Approaches in Metastatic and Recurrent Ewing Sarcoma

K. Lucas, Michael Huang, Michael A. Huang, 2010, Sarcoma.

Adoptive immunotherapy for EBV-associated malignancies.

K. Lucas, J. C. Barrett, J. Barrett, 1999, Cancer treatment and research.

The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.

G. Heller, B. Dupont, K. Lucas, 1996, Blood.

Epstein Barr virus induced lymphoma in a child with IPEX syndrome

K. Lucas, D. Ungar, M. Comito, 2008, Pediatric blood & cancer.

Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome

K. Lucas, D. Ungar, M. Comito, 2007, Bone Marrow Transplantation.

Post-transplant EBV induced lymphoproliferative disorders.

K. Pollok, K. Lucas, D. Emanuel, 1997, Leukemia & lymphoma.

Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation.

K. Cornetta, J. Wang, K. Lucas, 1998, Blood.

Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy

D. Krishnadas, F. Bai, K. Lucas, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

An Unusual Case of Relapsing Myositis In a 12-Year-Old Child

K. Lucas, A. Urbach, 1993, Clinical pediatrics.

Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation

W. May, K. Lucas, A. Ship, 2002, Bone Marrow Transplantation.

Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.

K. Lucas, T. Small, R. O'reilly, 1996, Important advances in oncology.

Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures.

K. Lucas, R. Burton, Qi Sun, 2002, Blood.

Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma

C. Schwartz, K. Lucas, J. Kaplan, 2008, Pediatric blood & cancer.

Fusion of B lymphoblastoid and tumor cells expressing different antibiotic resistance genes facilitates selection of stable hybridomas.

K. Lucas, L. Bao, 2008, Hybridoma.

The detection of CMV pp65 and IE1 in glioblastoma multiforme

Richard D Bruggeman, K. Lucas, C. Specht, 2011, Journal of Neuro-Oncology.

Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease.

D. Heilman, K. Lucas, D. Emanuel, 1998, Blood.

Targeting cancer-testis antigens in recurrent pediatric brain tumors

D. Krishnadas, F. Bai, K. Lucas, 2015, Journal of Neuro-Oncology.

Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes.

K. Pollok, K. Lucas, G. Mallory, 1997, Transplantation.

Immunotherapy with virus‐specific cytotoxic T lymphocytes after organ transplantation

K. Lucas, Qi Sun, 2006, Pediatric transplantation.

Wilms' tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord blood.

D. Krishnadas, K. Lucas, L. Bao, 2011, Leukemia research.

A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.

Q. Sun, K. Lucas, R. Burton, 2000, Human gene therapy.

Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.

K. Lucas, L. Bao, Kimberly Dunham, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cardiorespiratory decompensation following methylprednisolone administration.

K. Lucas, D. Howrie, C. Phebus, 1993, Pediatric hematology and oncology.

Sepsis Caused by Flavimonas oryzihabitans

D. Armstrong, T. Kiehn, K. Lucas, 1994, Medicine.

Cytomegalovirus Treatment in Pediatric Hematopoietic Stem Cell Transplant Patients

K. Lucas, Abby J Kim, Joshua J. Elder, 2017, Journal of pediatric hematology/oncology.

An instructive case of hypercalcemia preceding relapse of AML following allogeneic BMT

K. Lucas, M. Bayerl, M. Huang, 2011, Bone Marrow Transplantation.

Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts

K. Lucas, T. Small, R. O'reilly, 2004, Springer Seminars in Immunopathology.

Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts

K. Lucas, T. Small, R. O'reilly, 1997, Immunological reviews.

Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy

D. Krishnadas, K. Lucas, Michael A. Huang, 2015, Journal of immunology research.

Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.

W. Britt, K. Pollok, Q. Sun, 1999, Blood.

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis

G. Heller, G. Heller, D. Armstrong, 1996, Cancer.

K. Lucas, A. Freiberg, E. Frauenhoffer, 2010, Pediatric blood & cancer.

Catecholamine metabolites in ganglioneuroma.

K. Lucas, J. Blatt, M. Wollman, 1994, Medical and pediatric oncology.

Rapid Generation of CMV pp65-specific T cells for Immunotherapy

K. Lucas, L. Bao, Qi Sun, 2007, Journal of immunotherapy.

Use of Mesenchymal Stem Cells To Treat Pediatric Patients with Severe (Grade III–IV) Acute Graft Versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2007 .

CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.

K. Pollok, Q. Sun, K. Lucas, 1999, Cellular immunology.

Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.

D. Heilman, K. Pollok, K. Lucas, 1997, Journal of hematotherapy.

Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections

M. Cowan, K. Lucas, B. Horn, 2012, Journal of immunotherapy.

Relapse in acute lymphoblastic leukemia as a function of white blood cell and absolute neutrophil counts during maintenance chemotherapy.

K. Lucas, J. Blatt, M. Gula, 1992, Pediatric hematology and oncology.

Pharmacoeconomic Impact of Thiotepa-Containing Conditioning Regimens in a Pediatric Hematopoetic Stem Cell Transplant Center

K. Lucas, Abby J Kim, Joshua J. Elder, 2015 .

Microchimerism detection by human leucocyte antigen‐specific quantitative‐polymerase chain reaction analysis in recipients of allogeneic Epstein–Barr virus‐specific cytotoxic T lymphocytes

K. Lucas, Qi Sun, T. D. Erickson, 2005, British journal of haematology.

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

J. Kurtzberg, G. Broadwater, V. Prasad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol

R. D'Agostino, J. Massaro, P. Richardson, 2011 .

Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures.

K. Lucas, R. Burton, Qi Sun, 2002, Blood.